Back to search

Italy· 049607017

KLISYRI*unguento cutaneo 5 buste 250 g 10 mg/g

A tirbanibulin product containing tirbanibulina, registered in Italy by ALMIRALL S.A., on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC D06BX03

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · ITPublic registernormalisedKLISYRI*unguento cutaneo 5 buste 250 …ATCD06BX03REGISTER NO.049607017PACKS LISTED1CHECKEDJune 4, 2026

Where it is registered

Tirbanibulin is registered in 12 of 19 countries.

Countries holding a registration under ATC D06BX03 (tirbanibulin), each read from that country’s own register.

  • This record: Italy
  • 8 of them publish a price we can compare per daily dose

Tirbanibulin · ATC D06BX03

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Active substance
Tirbanibulina
Manufacturer
ALMIRALL S.A.
Country
Italy (IT)
ATC code
D06BX03
ATC class
Tirbanibulin
Reimbursed
Yes
Last checked
June 4, 2026

Packs & prices · 1

1 priced
  • aic
    049607017
    KLISYRI*unguento cutaneo 5 buste 250 g 10 mg/g
    EUR 79.57

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tirbanibulin in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tirbanibulin products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Klisyri
  • Liechtenstein · Klisyri
  • Norway · Klisyri

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a4fde550-ec25-424f-b1ff-09bc2f078fa5
GET /v1/drugs/a4fde550-ec25-424f-b1ff-09bc2f078fa5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "price": 79.57,
  "source": "aifa",
  "currency": "EUR",
  "strength": "TIRBANIBULINA 10MG/G 250MG 5 UNITA' USO DERMATOLOGICO",
  "substance": "Tirbanibulina",
  "equivalence_group": "MHW",
  "transparency_flag": null
}

See everything about tirbanibulin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.